This somatic mutation resulted from the substitution of glycine (G) by alanine (A) at position 469 in BRAF. This mutation has been reported in non-small-cell lung cancer (21–23) and in colorectal cancer (24) but not in oral cancer. This evidence concerns the gene BRAF and colorectal cancer.